Israel Cardiac Biomarkers Market (2025-2031) | Trends, Growth, Value, Forecast, Outlook, Analysis, Size & Revenue, Share, Competitive Landscape, Industry, Segmentation, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Cardiac Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 Israel Cardiac Biomarkers Market - Industry Life Cycle

3.4 Israel Cardiac Biomarkers Market - Porter's Five Forces

3.5 Israel Cardiac Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Cardiac Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Israel Cardiac Biomarkers Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cardiovascular diseases in Israel

4.2.2 Growing awareness about the importance of early detection and diagnosis of cardiac conditions

4.2.3 Technological advancements in cardiac biomarker testing and diagnostics

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of cardiac biomarker tests

4.3.2 High cost associated with cardiac biomarker testing

4.3.3 Limited reimbursement policies for cardiac biomarker tests

6.1 Israel Cardiac Biomarkers Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Cardiac Biomarkers Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Cardiac Biomarkers Market Revenues & Volume, By Myocardial muscle Creatine Kinase (CK-MB), 2021- 2031F

6.1.4 Israel Cardiac Biomarkers Market Revenues & Volume, By Troponins (T and I), 2021- 2031F

6.1.5 Israel Cardiac Biomarkers Market Revenues & Volume, By Myoglobin, 2021- 2031F

6.1.6 Israel Cardiac Biomarkers Market Revenues & Volume, By Brain Natriuretic Peptide (BNPs) or NT-proBNP, 2021- 2031F

6.1.7 Israel Cardiac Biomarkers Market Revenues & Volume, By Ischemia Modified Albumin (IMA), 2021- 2031F

6.1.8 Israel Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Cardiac Biomarkers Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Cardiac Biomarkers Market Revenues & Volume, By Myocardial Infarction, 2021- 2031F

6.2.3 Israel Cardiac Biomarkers Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F

6.2.4 Israel Cardiac Biomarkers Market Revenues & Volume, By Acute Coronary Syndrome, 2021- 2031F

6.2.5 Israel Cardiac Biomarkers Market Revenues & Volume, By Atherosclerosis, 2021- 2031F

6.2.6 Israel Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Cardiac Biomarkers Market, By Location of Testing

6.3.1 Overview and Analysis

6.3.2 Israel Cardiac Biomarkers Market Revenues & Volume, By Point of care testing, 2021- 2031F

6.3.3 Israel Cardiac Biomarkers Market Revenues & Volume, By Laboratory testing, 2021- 2031F

7.1 Israel Cardiac Biomarkers Market Export to Major Countries

7.2 Israel Cardiac Biomarkers Market Imports from Major Countries

8.1 Adoption rate of cardiac biomarker testing technologies in Israeli healthcare facilities

8.2 Number of research and development investments in cardiac biomarker technologies in Israel

8.3 Percentage increase in the number of cardiac biomarker tests conducted annually

9.1 Israel Cardiac Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Cardiac Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Israel Cardiac Biomarkers Market Opportunity Assessment, By Location of Testing, 2021 & 2031F

10.1 Israel Cardiac Biomarkers Market Revenue Share, By Companies, 2024

10.2 Israel Cardiac Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters